Duration: (1:56) ?Subscribe5835 2025-02-25T17:09:53+00:00
Numinus Bioscience: A Centre for Excellence
(1:56)
Numinus At The Forefront of MDMA | Payton Nyquvest - CEO Numinus Wellness
(16:5)
The Difference Between Natural \u0026 Synthesized | Sharan Sidhu - GM \u0026 Science Officer Numinus Wellness
(7:55)
Numinus Health: The Drive
(44)
EXCLUSIVE shareholder webinar with Numinus Wellness Founder and CEO Payton Nyquvest
(50:7)
Newest Numinus Production Process Has “The Potential To Transform The Sector”
(13:16)
Numinus Science Officer/GM Sharan Sidhu: We Won’t Patent IP That Makes Psychedelics Inaccessible
(15:24)
Numinus Wellness gets Health Canada approval for open-label study for MDMA-Assisted Therapy for PTSD
(8:38)
New Listing: Numinus Wellness (TSXV:NUMI)
(4:2)
Numinus Wellness takes major step forward with acquisition of Novamind
(4:50)
Numinus Wellness - Psychedelic Stock to Watch
(22:8)
Psychedelic-assisted psychotherapy is finding a home in Canada thanks to Numinus
(4:13)
Are Psychedelics A Viable Industry? | Numinus
(9:59)
Numinus Wellness: Building A Comprehensive Psychedelic-Assisted Therapy Ecosystem
(11:28)
Numinus’ Dr. Evan Wood: There is Nothing Like Psychedelics to Treat Mental Health Challenges
(16:38)
Numinus Wellness CEO Discusses MAPS Partnership \u0026 How Psychedelics Will Change Society
(19:19)